Q: What is Jemperli used for?

Jemperli is used to treat endometrial cancer and mismatch repair deficient solid tumors .

Q: How does Jemperli work?

Immune System Activation Jemperli is a type of immunotherapy known as a monoclonal antibody. It works by targeting the programmed death receptor-1 (PD-1) pathway, which is a checkpoint the body uses to manage immune responses. Under normal conditions, the PD-1 pathway helps prevent the immune system from attacking the body's own healthy cells. However, some cancer cells can hijack this pathway. By binding to PD-1 receptors on T-cells (a type of white blood cell), cancer cells can send a signal that tells the immune system to stop attacking. This allows the tumor to grow and spread undetected. How Jemperli Works Jemperli works by blocking the PD-1 receptor. When the medication binds to these receptors, it prevents cancer cells from sending the stop signal to the immune system. This helps the body's natural defenses to: Identify cancer cells as harmful invaders. Reactivate T-cells so they can attack the tumor. Slow down or stop the progression of the cancer. This treatment is often used for cancers that have a genetic feature called mismatch repair deficiency (dMMR). These tumors are more likely to be recognized and attacked by the immune system once the PD-1 pathway is blocked.

Q: What are the active ingredients in Jemperli?

The active ingredient in Jemperli is dostarlimab .

Q: What are the side effects of Jemperli?

Common side effects of Jemperli may include: Fatigue Nausea Diarrhea and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Jemperli?

Jemperli belongs to the PD-1 inhibitor drug class.

Q: What is the dosage of Jemperli and how do I take it?

How Jemperli is Administered Jemperli is given as an injection into a vein, which is called an intravenous (IV) infusion. This procedure is performed by a healthcare professional in a medical setting, such as a hospital or clinic. Each infusion session typically lasts for a specific period of time as determined by your healthcare team. Dosing Schedule The treatment is generally administered in cycles. It is often given once every few weeks for the first several doses. After this initial phase, the frequency of the infusions may change to a longer interval between treatments. Your doctor will decide how many treatments you need and the exact timing based on your condition and how well you tolerate the medication. Missed Doses It is important to receive every scheduled dose of Jemperli. If you miss an appointment for an infusion, contact your doctor or healthcare provider immediately to reschedule. They will provide guidance on the best time to receive your next dose to ensure the treatment remains effective.

Q: Is Jemperli safe during pregnancy and breastfeeding?

Pregnancy Jemperli can cause harm to a developing fetus. Healthcare providers typically require a pregnancy test before starting treatment to confirm the patient is not pregnant. Individuals who can become pregnant should use effective birth control during treatment and for at least 4 months after the final dose. If a patient becomes pregnant while receiving this medication, they should contact their doctor immediately to discuss the potential risks. Breastfeeding It is not known if Jemperli passes into breast milk. Because of the risk of serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for 4 months after the last dose.

Q: What forms and strengths does Jemperli come in?

Jemperli is available in the following form: Injection: A sterile, preservative-free solution supplied in a single-dose vial. The medication is a clear to slightly opalescent, colorless to yellow liquid intended for dilution and intravenous infusion.

Q: What is the FDA approval status of Jemperli?

FDA Approval and Indications Jemperli (dostarlimab-gxly) is an FDA-approved immunotherapy. It is used to treat adults with specific types of cancer that are mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H). These markers are identified through laboratory testing. The FDA has approved Jemperli for the following conditions: Endometrial Cancer: It is approved for use with the chemotherapy drugs carboplatin and paclitaxel, followed by Jemperli alone, for primary advanced or recurrent endometrial cancer that is dMMR or MSI-H. It is also approved as a single treatment for dMMR recurrent or advanced endometrial cancer that has worsened after previous treatment with platinum-based chemotherapy. Solid Tumors: It is approved as a single treatment for adults with dMMR recurrent or advanced solid tumors that have progressed after prior treatment and when no other satisfactory treatment options are available. Regulatory Status The approval for treating solid tumors was granted under the FDA accelerated approval program. This means the drug was approved based on early evidence showing it is likely to provide a clinical benefit. Further studies may be required to confirm these benefits to maintain this specific approval. Jemperli does not have any boxed warnings or special safety programs (REMS) required by the FDA.

Question 1

What is Jemperli?

Accepted Answer

Jemperli is a type of immunotherapy known as a monoclonal antibody. It works by blocking a specific protein called programmed death receptor-1 (PD-1) found on certain cells.

By blocking this protein, the medication helps the body's immune system recognize and attack cancer cells. This action is intended to slow or stop the growth of tumors.

Question 2

What is Jemperli used for?

Accepted Answer

Jemperli is used to treat endometrial cancer and mismatch repair deficient solid tumors.

Question 3

How does Jemperli work?

Accepted Answer

Immune System Activation

Jemperli is a type of immunotherapy known as a monoclonal antibody. It works by targeting the programmed death receptor-1 (PD-1) pathway, which is a checkpoint the body uses to manage immune responses.

Under normal conditions, the PD-1 pathway helps prevent the immune system from attacking the body's own healthy cells. However, some cancer cells can hijack this pathway. By binding to PD-1 receptors on T-cells (a type of white blood cell), cancer cells can send a signal that tells the immune system to stop attacking. This allows the tumor to grow and spread undetected.

How Jemperli Works

Jemperli works by blocking the PD-1 receptor. When the medication binds to these receptors, it prevents cancer cells from sending the stop signal to the immune system. This helps the body's natural defenses to:

Identify cancer cells as harmful invaders.
Reactivate T-cells so they can attack the tumor.
Slow down or stop the progression of the cancer.

This treatment is often used for cancers that have a genetic feature called mismatch repair deficiency (dMMR). These tumors are more likely to be recognized and attacked by the immune system once the PD-1 pathway is blocked.

Question 4

What are the active ingredients in Jemperli?

Accepted Answer

The active ingredient in Jemperli is dostarlimab.

Question 5

What are the side effects of Jemperli?

Accepted Answer

Common side effects of Jemperli may include:

Fatigue
Nausea
Diarrhea
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Jemperli?

Accepted Answer

Jemperli belongs to the PD-1 inhibitor drug class.

Question 7

What is the dosage of Jemperli and how do I take it?

Accepted Answer

How Jemperli is Administered

Jemperli is given as an injection into a vein, which is called an intravenous (IV) infusion. This procedure is performed by a healthcare professional in a medical setting, such as a hospital or clinic. Each infusion session typically lasts for a specific period of time as determined by your healthcare team.

Dosing Schedule

The treatment is generally administered in cycles. It is often given once every few weeks for the first several doses. After this initial phase, the frequency of the infusions may change to a longer interval between treatments. Your doctor will decide how many treatments you need and the exact timing based on your condition and how well you tolerate the medication.

Missed Doses

It is important to receive every scheduled dose of Jemperli. If you miss an appointment for an infusion, contact your doctor or healthcare provider immediately to reschedule. They will provide guidance on the best time to receive your next dose to ensure the treatment remains effective.

Question 8

Is Jemperli safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Jemperli can cause harm to a developing fetus. Healthcare providers typically require a pregnancy test before starting treatment to confirm the patient is not pregnant.

Individuals who can become pregnant should use effective birth control during treatment and for at least 4 months after the final dose. If a patient becomes pregnant while receiving this medication, they should contact their doctor immediately to discuss the potential risks.

Breastfeeding

It is not known if Jemperli passes into breast milk. Because of the risk of serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for 4 months after the last dose.

Question 9

What forms and strengths does Jemperli come in?

Accepted Answer

Jemperli is available in the following form:

Injection: A sterile, preservative-free solution supplied in a single-dose vial.

The medication is a clear to slightly opalescent, colorless to yellow liquid intended for dilution and intravenous infusion.

Question 10

What is the FDA approval status of Jemperli?

Accepted Answer

FDA Approval and Indications

Jemperli (dostarlimab-gxly) is an FDA-approved immunotherapy. It is used to treat adults with specific types of cancer that are mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H). These markers are identified through laboratory testing.

The FDA has approved Jemperli for the following conditions:

Endometrial Cancer: It is approved for use with the chemotherapy drugs carboplatin and paclitaxel, followed by Jemperli alone, for primary advanced or recurrent endometrial cancer that is dMMR or MSI-H. It is also approved as a single treatment for dMMR recurrent or advanced endometrial cancer that has worsened after previous treatment with platinum-based chemotherapy.
Solid Tumors: It is approved as a single treatment for adults with dMMR recurrent or advanced solid tumors that have progressed after prior treatment and when no other satisfactory treatment options are available.

Regulatory Status

The approval for treating solid tumors was granted under the FDA accelerated approval program. This means the drug was approved based on early evidence showing it is likely to provide a clinical benefit. Further studies may be required to confirm these benefits to maintain this specific approval. Jemperli does not have any boxed warnings or special safety programs (REMS) required by the FDA.

Question 11

What should I know about Jemperli and cost?

Accepted Answer

Factors Influencing Cost

Jemperli is a specialty medication administered as an intravenous (IV) infusion by a healthcare professional. Because it is not a drug you purchase at a standard retail pharmacy, the total cost typically includes several different components:

Insurance Coverage: Most private insurance plans, Medicare, and Medicaid may cover Jemperli, but your specific out-of-pocket expenses will depend on your plan's deductibles, copayments, or coinsurance.
Prior Authorization: Many insurance providers require a prior authorization process, where your healthcare provider must submit documentation to confirm the medical necessity of the treatment before coverage is approved.
Administration Fees: In addition to the cost of the medication itself, you may be billed for the clinical services, supplies, and nursing time required to administer the infusion.
Facility Type: The price can vary depending on whether the treatment is received in a hospital outpatient setting, a doctor's office, or a specialized infusion center.

Financial Assistance

For patients who are uninsured or have high out-of-pocket costs, financial assistance programs may be available. These programs are often provided by the manufacturer or through third-party foundations to help eligible individuals access treatment. Patients are encouraged to speak with their healthcare team or a financial counselor at their treatment facility to explore these options and obtain a specific cost estimate.

Jemperli

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Jemperli

Hospitals.net Disclosure